Scientists discover new compounds that block enzyme linked to diabetes

AI Insight

Researchers developed a one-pot multicomponent synthesis method to efficiently produce polyhydroquinoline compounds, which were then tested for their biological activity. The synthesized polyhydroquinolines demonstrated inhibitory effects against α-glucosidase, an enzyme that breaks down carbohydrates into glucose. This finding identifies polyhydroquinolines as a new chemical class with potential therapeutic applications for managing blood sugar levels.

Why it matters

α-glucosidase inhibitors are used to control postprandial blood glucose levels in diabetes management. This facile synthetic method could enable cost-effective production of new anti-diabetic drug candidates, potentially offering alternative treatments for Type 2 diabetes and related metabolic disorders.